NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 600165 for the last quarter is 68.88 M CNY, and it's 19.66% higher compared to the previous quarter. The net income of Q3 24 is -54.58 M CNY.